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ABSTRACT
Title: Structural and Regenerative Aspects of the Hydra Head Activator
Neuropeptide in the Newt, Notophthalmus viridescens
Name: Fuentes, Ernesto Jorge
University of Dayton, 1992
Advisor: Dr. P.A  Tsonis
The hydra head activator (HHA) neuropeptide was first isolated from the 
freshwater Cnidaria, Hydra vulgaris (formerly Hydra attenuata). Subsequent studies 
have revealed its presence and conserved sequence (NH2-pGlu-P-P-G-G-S-K-V-I-L-F- 
COOH) in many species including mammals. In regenerating hydra, the peptide 
influences head-specific differentiation of epithelial cells and acts as a mitogen. In 
this study, the presence of the HHA peptide and its influence on regenerating newt 
limbs (Notophthalmus viridescens) was investigated. Immunohistological analysis 
localized the HHA peptide in the adult newt brain, eye, intestine, and regenerating
blastema.
Nine-day limb regenerates were completely denervated by transecting the 
brachial nerves. The following day, HHA-soaked beads were implanted into the 
blastema under the wound epithelium and regeneration was studied for two weeks. 
Results suggest a slight progression in blastema growth occurred compared to
denervated controls.
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The structure of the HHA neuropeptide has been previously studied using 
NMR, CD, and Raman spectroscopy and determined to contain between 62-67% 
anti-parallel ^-pleated sheet, and predicted to assume a /?-tum near the amino 
terminus. We have utilized spectroscopic data with the Double-Iterated Kalman 
Filter (DIKF) technique and CHARMm molecular mechanics to produce a molecular 
model of the HHA peptide. Consistent with the secondary structure prediction, an 
anti-parallel 0-pleated sheet topology was evident from the serine amino acid to the 
carboxyl terminus. Additionally, a/J-tum occurred near the amino carboxyl terminus. 
Results indicate that fluctuations occurring at both termini may serve to stabilize the 
structure ultimately allowing the amino terminus access to its receptor protein.
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CHAPTER 1.
Review of Literature
1
The study of regenerative processes offers insight into the regulation and 
maintenance of cellular growth and differentiation. Since the pioneering 
investigations of Trembley (1740), Spallanzani (1769) and numerous others, 
regeneration of tissues and organs has been documented in many organisms such as 
hydra, killfish, catfish, salamanders, and mammals (Goss, 1969). In mammals, 
regeneration is limited, while urodele (tailed) amphibians and the cnidarian hydra 
have been studied extensively for their broad regenerative capabilities (Ord & 
Stocken, 1984).
In 1769, Spallanzani was the first to report on the regenerative potential of 
salamanders. In his account, Spallanzani describes the phenomena of tail and limb 
regeneration in several species (Spallanzani, 1769). Today, the urodele amphibians 
such as the newt (Notopthalmus viridescens) and the axolotl (Ambystoma mexicanum), 
the only vertebrates that are able to undergo regeneration as adults, have become 
model systems for the study of regeneration phenomenon and limb pattern formation.
An urodele amphibian can regenerate an experimentally amputated limb at 
any level on the proximal-to-distal axis (shoulder to fingertip) beginning at the plane 
of amputation (reviewed by Stocum, 1984). Upon amputation of the limb, wound 
healing begins by the migration of epidermal cells to the amputation plane, forming 
the wound epidermis. These epidermal cells accumulate at the wound site yielding 
a thickened apical epidermal cap. Mesodermal cells, such as cartilage and muscle, 
beneath the epidermal cap dedifferentiate to unspecific, embryonic-like cells resulting 
in an apical bud termed blastema. The blastema enlarges due to cellular
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proliferation, redifferentiates, and undergoes pattern specification. The final stages 
of limb regeneration involve morphogenesis whereby the limb stump extends distally 
with concomitant formation of any missing digits (Goss, 1969; Stocum, 1984; Tsonis, 
1991). Detailed morphological accounts and specific staging systems for limb 
regeneration have been published elsewhere and will not be discussed here (Iten and 
Bryant, 1973; Tank et al., 1976; Washabaugh and Tsonis, 1991).
The limb regeneration process is inextricably dependent upon the formation 
of an epithelial wound covering, adequate innervation (presence of nerves), blastema 
cells, and appropriate chemical "factors" (Liversage 1987; Tsonis 1991). The apical 
epithelial covering provides protection, positional cues and patterning information. 
The importance of the wound epithelium is underscored by the failure of limbs to 
regenerate when the epidermal cap is UV-irradiated or completely removed 
(reviewed by Stocum, 1985).
An adequately innervated limb will regenerate normally while denervation 
prevents or delays the formation of a limb regenerate (reviewed by Singer, 1952). 
Singer’s "nerve threshold" theory postulates that nerves provide a trophic or 
neurotrophic influence on the blastema only when sufficient innervation is present 
Therefore, below some particular threshold of nerves, neurotrophic activity ceases 
and regeneration is inhibited. Specifically, denervation has been reported to affect 
the blastema cell cycle at the Gj (Maden, 1978 and 1979) and G2 stages (Tassava, 
1978). Moreover, denervated limbs have reduced DNA and protein synthesis which
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can be partially rescued by the infusion of nerve extracts (Lebowitz and Singer, 1970; 
Jabaily and Singer, 1977).
The local chemical environment surrounding the regenrating limb seems to be 
crucial. Liversage (1985) proposes the "hormonal milieu" concept which implies that 
a sufficient and specific quantity of hormonal background is necessary for 
regeneration to proceed. This point is emphasized by the inhibition of regeneration 
upon hypophysectomy (Liversage and Globus, 1977; Liversage et a t, 1985).
The process of limb regeneration is one of specific cellular responses to 
trophic, mitogenic, and morphogenic factors (Brockes, 1984; Liversage, 1987). These 
factors act at the cellular level and control specific aspects of cell differentiation and 
proliferation. These factors include retinoids, growth factors, and peptide hormones.
Retinoids
The retinoids are a class of compound containing a hydrocarbon ring and an 
attached conjugated hydrocarbon chain whose terminus is polar. These compounds 
are synthesized in animals from plant carotenoids. A representative member of these 
compounds is Vitamin A  (retinol) which is synthesized and stored in the liver and 
released to tissues via the circulatory system. Once in the tissues, retinol is 
carboxylated and the resulting product termed retinoic acid (Blomhoff et al., 1990).
Retinoic acid (RA) seems to have two major functions. RA appears to be 
involved in epithelial cell differentiation and is intimately involved in the positional 
memory of regenerating and developing cells (reviewed by Brockes, 1989). In
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regenerating urodele limbs, the blastema is "proximalized" due to RA. The positional 
memory of the cells is altered and the blastema behaves as though it were derived 
from a more proximal location (Thomas & Stocum, 1984; Maden, 1982). These 
effects are dose and time-dependent and most pronounced when administered early 
in blastema formation (Maden et al., 1985).
The urodele limb with RA has become an widely used experimental system 
for limb developmental and regeneration studies. The action of RA has been 
proposed to be mediated via a receptor-ligand complex analogous to steroid-hormone 
complexes. In the current model, the hormone binds to the monomeric receptor 
inducing translocation to the nucleus and/or receptor dimerization. The dimer then 
binds to its target DNA response element which influences transcriptional events 
(Beato, 1989; Evans, 1988). Recently, a gene was isolated (RARa) that shares 
homology with the steroid hormone receptor superfamily and codes for a protein that 
binds retinoic acid (Giguere et al., 1987; Petkovich et al., 1987). Giguere et al. (1989) 
have investigated the spatial expression of the RARa gene in blastema tissue and 
found no significant differences along the proximal-to-distal axis as one might expect 
for a morphogen that alters positional memory. To date several other retinoic acid 
receptors have been isolated leading to the designations of RARa, RAR/J, RARy, 
and RXRa (Blomhoff, 1990). Evidence now suggests that these receptors may form 
dimers among themselves and/or with other steroid receptors (thyroid hormone and 
vitamin D3 receptors) adding an additional level of complexity to their mode of action 
(Bugge et al., 1992). In addition to the nuclear RAR, cytoplasmic retinoic and retinol
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binding proteins (CRABP and CRBP) have been isolated (Blomhoff, 1990). Then- 
function is elusive, however, there is speculation that they may act to sequester RA 
and retinol for later use by the cell.
Growth factors
Several growth factors have been associated with neurotrophic and mitogenic 
events. Most noteworthy are the fibroblast (Carlone and Mescher, 1985) and glilial 
(Brockes & Kintner, 1986) growth factors. The fibroblast growth factor (FGF) has 
been isolated from the brain and pituitary by several laboratories (Gospodarowicz, 
1974; Westall et aL, 1978). In each case that mitogenic activity was found, however, 
there remain discrepancies between the chemical characterization of each isolate. 
The mitogenic activity of FGF was initially found in fibroblasts and since then a 
proliferative effect has been noticed on newt regenerating blastema (Mescher & Loh, 
1981).
The glial growth factor (GGF), a true neuromitogen, was first identified by its 
mitotic activity on rat Schwann cells - cells which notoriously lack response to 
mitogens (Raff et aL, 1978). The GGF is a basic protein with an apparent molecular 
weight of 31,000 daltons. In urodele amphibians it is present in nervous and 
blastemal tissue but upon denervation is no longer detectable (Brockes & Kintner, 
1986). Furthermore, GGF was responsible for the induction of mitosis as seen 
through an increased thymidine labelling index.
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Peptides
Although most studies concerning mitotic factors have centered on proteins, 
recent studies have shown that neuropeptides and peptide hormones may also possess 
mitotic activity (Globus & Alles, 1990). Bombesin was first isolated from frog skin 
and is known to elicit the release of a host of other peptides including insulin and 
prolactin (Rozengurt & Sinnett-Smith, 1983). Rozengurt and Sinnett-Smith were able 
to show that bombesin is a potent mitogen on 3T3 cells and works synergistically with 
insulin. Recently, Globus and Alles (1990) have purportedly detected members of 
the tachykinin family (eledoisin, kassinin, substance K and neuromedin K) and the 
non-tachykinin bombesin and met-enkelphalin in newt brain and spinal cord, however
their localization in the blastema was not well defined.
In the same study, substance P (SP) was successfully localized and 
characterized in the blastema. It was predominately distributed along the periphery 
of epidermal cells while the basal germinative epidermal layer remained unreactive. 
In further experiments, the intensity of SP antisera reaction was found to correlate 
with the expected density of innervation in the epidermis. Previously, it was shown 
that SP behaves as a mitogen in cultured blastema cells and its action could be 
suppressed by the inclusion of anti-SP in the culture (Globus et al., 1983). Together, 
this data suggests a possible link between the localization of SP and its mitogenic 
effect on the blastula. Possibly, its role is to act on epidermal cells which in turn 
release factors which are responsible for the observed mitotic effect. Triparte control 
of limb regeneration was proposed by Globus (1978). In this model, nerves, the
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apical epidermal cap, and insulin are essential for limb regeneration. Subsequent 
studies revealed insulin to be a potent promoter of cultured blastema cells 
(Vethamany-Globus, 1987). From in vivo experiments, somatostatin, a known 
inhibitor of insulin release, was suggested to be responsible for the inhibition of limb 
regeneration (Vethamany-Globus, 1987).
The hydra head activator (HHA) neuropeptide, as the name implies, was first 
recognized in the freshwater Cnidaria, Hydra attenuata. Subsequent studies have 
revealed its conserved presence through many species including mammals 
(Bodenmiiller and Schaller, 1981). In hydra, the head activator neuropeptide 
functions as a growth and differentiation factor. In a dose dependent fashion, the 
neuropeptide is mitogenic to all cell types arrested at the G2 transition. As a 
differentiation factor, the HHA neuropeptide targets epithelial and interstitial stem 
cells. These cells, once stimulated by the HHA neuropeptide will differentiate to 
head- specific ectodermal, endodermal, or neural cells.
In addition to HHA’s conserved sequence, there is evidence that the growth- 
controlling function of the peptide may also be preserved. The HHA has been 
isolated from the human hypothalamus and brain tissues of several other mammalian 
species (Bodenmiiller & Schaller, 1981). In developing rat embryos, the expression 
of HHA appears early and lasts throughout development (Schaller et aL, 1989a). 
Furthermore, HHA is also present in tumors and tumor cell lines of neural and 
endocrine origin (Schaller, 1985). One particular study suggests that the HHA
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peptide acts as an autocrine growth factor at the G^mitosis transition of a 
neuroblastoma cell line (Schaller et al., 1989b).
Interestingly, the activity of the HHA in other commonly used regenerative 
model organisms has not been reported in the literature. In amphibian urodeles, it 
seems to be a logical candidate as a neuromitogen - it originates in neural tissue and 
possesses mitogenic activity.
The essential role of nerve cells seems to be linked to the several growth and 
stimulatory factors they produce and subsequently release. Other chemical factors 
such as peptide hormones and retinoids also seem to play a crucial role in 
regeneration. These factors have been implicated in the induction of mitosis and 
morphogenesis and hence are considered mitogenic and morphogenic factors. 
Additionally, the formation of chemical gradients for differential expression of these 
factors may be the final influencing determinant for the sustained progression of 
development and regeneration.
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CHAPTER 2.
Expression of Hydra Head Activator in Newt Tissues and 
Effects on Limb Regeneration
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Abstract
In this study, the presence of the hydra head activator (HHA) neuropeptide 
and its influence on regenerating newt limbs (Notophthalmus viridescens) was 
investigated. Immunohistological analysis has localized the HHA neuropeptide in the 
adult newt brain, eye, intestine, and regenerating blastema. Experiments in which 9 
day limb regenerates were denervated and subsequently implanted with HHA-soaked 
beads suggest a slight progression of blastema growth compared to denervated
controls.
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Introduction
The adult newt, Notophthalmus viridescens, is widely known for its ability to 
regenerate an injured or surgically amputated limb. Initially, epidermal cells migrate 
from the periphery of the wound producing an apical epidermal layer. This wound 
epithelium is crucial to the regenerative process; in its absence, limb regeneration 
does not proceed. As limb regeneration continues, differentiated cells such as muscle 
and cartilage dedifferentiate into embryonic-like mesenchymal cells. These cells, 
known as blastema cells, proliferate and begin to accumulate beneath the wound 
epithelium. Eventually, the blastema cells re-differentiate into the new cartilage and 
bone cells of the regenerating limb. Finally, morphogenesis will ensue replacing any 
missing structures of the amputated limb (Goss, 1969; Tsonis,1991).
The nerve-dependence in newt limb regeneration has been well documented 
(Singer, 1952). It has been shown that adequate innervation is necessary for proper 
limb regeneration and that a completely denervated limb will not regenerate. 
However, this nerve- dependence of the limb blastema is required only during the 
first 17 days post-amputation. Once a nerve-dependent blastema has been deprived 
of its nerve supply, it ceases to grow and is subsequently resorbed. In contrast, a 
nerve-independent blastema (blastema older than »  17 days) is able to re­
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differentiate and morphogenesis can lead to a regenerated limb (Singer and Craven, 
1948).
On the molecular level, denervation of the limb blastema results in the 
reduction of protein, RNA, and DNA synthesis. Tassava and colleagues have shown 
that in the absence of nerves, dedifferentiation of stump cells does occur along with 
DNA synthesis, but cell division is arrested (Tassava, 1978; Mescher, 1982). In 
contrast, Maden (1978) has proposed that nerve fibers influence either the total 
number of blastema cells cycling or the rate at which they cycle by varying the length 
of the Gi phase. Tassava et al. (1987) suggest that the blastema cell cycle is a 
"punctuated" phenomena whereby cells are constantly alternating between active 
cycling and transient quiescence. In any case, it seems that adequate innervation may 
provide cues which allow arrested cells to continue cycling and hence advance the 
proliferation of the blastema.
The reliance of the early blastema upon adequate innervation has been 
described by Singer (1952) as a neurotrophic phenomenon. This neurotrophic 
phenomena is hypothesized to originate in nerve fibers and postulated to promote 
blastema cell proliferation. Although the identity of this neurotrophic "factor(s)" 
remains unknown, several candidate molecules have been investigated (Carlone and 
Mescher, 1985; Brockes, 1984). Furthermore, several lines of evidence strongly 
suggest the neurotrophic "factor" is a protein or peptide molecule (Singer et al., 
1976). Separate studies have implicated divalent calcium (Foret, 1973), cyclic 
nucleotides (cAMP and cGMP) (Globus et al., 1987), and inositol phosphates (Tsonis,
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1991) as mediators of this neurotrophic effect. Recently, Globus and Alles (1990) 
investigated the presence of several neuropeptides such as substance P, neurotensin, 
and bombesin in the regenerating limb blastema, however their specific roles in 
regeneration were not detailed.
In hydra, a neuropeptide is responsible for head-specific growth and 
differentiation of epithelial and interstitial cells (Schaller et al., 1989a). This 
neuropeptide, the hydra head activator (HHA) was first isolated from the freshwater 
Cnidaria, Hydra vulgaris (formerlyHydra attenuata) (Schaller and Bodenmuller, 1981). 
Subsequent studies have revealed its presence and conserved amino acid sequence 
(pGlu-Pro-Pro-Gly-Gly-Ser-Lys-Val-Ile-Leu-Phe) in many species including mammals 
(Bodenmuller and Schaller, 1981).
In addition to HHA’s conserved sequence, there is evidence that its growth­
controlling function may also be preserved. In developing rat embryos, the 
expression of HHA appears early in the brain and intestine, lasting throughout 
development (Schaller et al., 1977). The HHA has been found in tumors and tumor 
cell lines of neural and endocrine origin (Schaller et ah, 1988). In neuroblastoma cell 
lines, cellular growth is dependent upon the neuropeptide where it acts as an 
autocrine growth factor at the G^mitosis transition (Schaller et al., 1989b). Kajiwara 
and Sato (1986) have shown that the HHA stimulates DNA, RN A  and protein 
synthesis in cultured chick embryo brain cells. This study also provides evidence that
HHA induces an increase in cellular cAMP with concomitant decrease in cGMP. We
have raised the possibility that the HHA may have an influential role in the
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regenerating newt limb. In this study, the presence of the HHA neuropeptide and 
its ability to promote blastema proliferation was investigated.
Materials and Methods
Animals and surgical techniques
Adult newts, Notophthalmus viridescens, were obtained from Charles Sullivan 
Co., Nashville, Tennessee were maintained in treated tap water at 21-25°C and fed 
raw chicken or beef liver two or three times weekly. Prior to all surgical procedures, 
animals were anesthetized with 0.01% phosphate-buffered aminobenzoic acid ethyl 
ether at pH 7 (Sigma Chemical Co.). Forelimb amputations were bilateral at the 
mid-radius/ulna level. Left forelimbs were denervated using fine forceps by severing 
the brachial nerves distal to the brachial plexus (Goldhamer and Tassava, 1987). The 
success of denervation was demonstrated by lack of limb movement and lack of 
response to sensory stimulation. Bead implantations were performed on ten-day limb 
regenerates using a fine, glass microinjection needle. In each case, approximately 4-5 
beads were implanted into the blastema through the wound epidermis. Control limbs 
were punctured and received no implant beads. Previous studies have determined 
that beads alone have no effect on the limb regenerate (our previous studies, Wanek 
et al., 1991).
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Immunohistochemistry
Adult newts were amputated as previously stated. At one or two weeks post­
amputation, limbs and tissue specimens were excised and immediately frozen in 
O.C.T. compound (Miles, Elkhart, IN). Cryostat sections were cut longitudinally 
between 6 and §um along the anterior-posterior axis and placed on precleaned slides.
The primary antibody to the HHA neuropeptide (code K-8303) was raised in 
rabbit (Ekman et al., 1990) and diluted 1:50 with phosphate-buffered saline (PBS). 
Prior to staining, all sections were rehydrated using PBS containing 5% goat serum 
albumin. Primary staining was visualized using a 1:20 dilution of IgG fluorescein 
isothiocyanate (FITC)-conjugated goat anti-rabbit antiserum (Sigma Chemical Co.).
Preparation of bead implants
HHA neuropeptide (Sigma Chemical Co.) was monomerized at a 
concentration of 0.45mM using 3M ammonium sulfate as previously described
(Bodenmuller et al., 1986). This stock solution was subsequently diluted to 13.4/xM 
(0.017mg m l1) with 1% BSA and 0.1M NaCl and used to completely saturate AG1-
X4 basic anion exchange resin beads (Bio-Rad, 105-250 /4m diameter) overnight at 
4°C. These beads have been used in previous studies to slowly deliver hydrophobic 
retinoid molecules locally (Wanek et al., 1991). Assuming 100% adsorption by the 
beads, the maximum amount of peptide per bead would be approximately 3 /4g.
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Histological analysis
At appropriate times, experimental and control limbs were removed, fixed 
using Bouin’s fixative and decalcified with 10% trichloroacetic acid. Treated limbs 
were imbedded in paraffin and sectioned longitudinally at 8-lQum. Sections from 
each limb were taken through a graded ethanol series and processed using Gomori’s 
trichrome stain and hematoxylin. Brightfield microscopy was used for tissue section 
analysis.
Results and Discussion
Immunolocalization
The presence of the HHA neuropeptide in several species including mammals 
has been documented (Bodenmiiller et al., 1981; ScMwller et al., 1977). In these 
studies, the peptide was either chemically extracted or detected by immunological 
assay in rat and human tissues. Specifically, significant amounts were found among 
the following tissues: intestine, eye and brain. Blood serum also contained the 
neuropeptide, and it was found at elevated levels in individuals with brain tumors 
(Schaller et al., 1988). Our results indicate the expression of the neuropeptide in 
adult newt tissues. Using polyclonal antisera and indirect fluorescence detection, the 
HHA immunoreactivity was evident in newt intestine, eye, limb blastema (Fig. 1), and 
brain (data not shown). Intestinal tissue demonstrated a high degree of fluorescence 
when exposed to HHA antisera (Fig lb). Staining was cytoplasmic and most intense
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on the lumenal epithelial layer. This tissues demonstrated the highest amount of 
immunoreactivity. The newt eye also displayed HHA immunoreactivity (Fig. lc). 
Fluorescence patterns in the eye was strong for the outer corneal epithelial layer; 
only slight staining was evident for the interior corneal cells.
In addition to the above tissues, regenerating limbs (17 days post-amputation) 
were examined by immunofluorescence. Figure la  shows distinct fluorescence in the 
apical epidermal layer of the limb regenerate. The intensity of staining was greatest 
on peripheral epidermal layers and diminished near the basal germative layer. 
Immunoreactivity was also evident in the mesenchymal cells, but at a lower level than 
found in the epidermis. These results are in agreement with previous studies of 
other, unrelated neuropeptides. Globus and Alles (1990) investigated several 
tachykinin (substance P, eledoisin, kassinin, substance K and neuromedin K) and non­
tachykinin (bombesin, nerotensin, and net-enkephalin) neuropeptides. Of these, 
substance P yielded the strongest immunoreactivity displaying a similar staining 
pattern to that found with the HHA neuropeptide. An identical staining pattern was 
obtaiMwd for limb regenerates which were denervated as in Materials and Methods 
(data not shown). This result suggests the origin of the HHA is the limb itself, 
possibly the wound epithelium.
Limbs treated with exogenous HHA neuropeptide
Twenty-one adult newts were amputated bilaterally and allowed to regenerate 
nine days, at which time left forelimbs were denervated. On day ten, eleven
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denervated limb regenerates were implanted with HHA-soaked beads. The 
innervated right limbs of each animal served as control for normal regeneration. The 
remaining ten animals were used as negative controls, representing denervation alone.
In general, denervated control limbs became arrested and did not progress 
further (Fig. 2b). Similar results have been reported extensively in the literature 
(Singer, 1952). No re-differentiation was evident and the density of blastema cells 
were noticeably reduced when compared to normal regenerates (Fig. 2a). 
Experimental limbs containing HHA-soaked beads, demonstrated a slight 
accumulation of blastema cells in 2/11 cases. As depicted in Fig. 2c, one can see an 
apparent increase in blastema cells in treated limb stumps, though not an 
accumulation as in normal regenerates. It could be that the HHA has a limited 
effect, but it does not seem to be sufficient as a neurotrophic factor. The presence 
of the HHA in the wound epithelium could argue for a signalling function in the 
regenerating limb, possibly via cyclic nucleotides. Further studies on the function(s) 
of the HHA and its receptor molecule could elucidate the specific functions of the 
neuropeptide on regenerative tissues other than hydra.
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Figure 1. Hydra head activator immunoreactivity in newt tissues. (A) Normal 17-day 
newt regenerating limb blastema (we, wound epithelia; b, blastema cells), 75 X. (B) 
Newt intestinal tissue (1, lumen), 150 X  (C) Eye tissue (comeal epithelia), 150 X
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Figure 2. Effect of exogenous administration of the hydra head activator on 
regenerating newt limb blastema. In all figures, the dashed line represents the plane 
of amputation. The radius (r) and ulna (u) are depicted. Mesenchymal blastema 
cells (b) are labelled. Photographs were taken at 75 X. (A) A four-week normal, 
innervated regenerate displaying a full blastema and thick epidermal cap. (B) A  four- 
week blastema which was denervated nine days after amputation. This blastema 
shows few mesenchymal cells and a thin epidermal cap. (C) This blastema was 
amputated and denervated as in (B). However, exogenous HHA was delivered 
locally (arrow) to the regenerate via a HHA-soaked bead. This regenerate displays 
a slight progression of blastema cells over (B), however it does not reach the size of 
normal regenerates (A).
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CHAPTER 3.
On the Three-dimensional Structure o f the Hydra Head Activator Neuropeptide
31
Abstract
The structure of the Hydra head activator (HHA) neuropeptide has been 
previously studied using NMR, CD, and Raman spectroscopy and determined to 
contain between 62-67% anti-parallel ^-pleated sheet, and predicted to assume a 
tum near the amino terminus. We have utilized spectroscopic data with the Double- 
Iterated Kalman Filter (DIKF) technique and CHARMm molecular mechanics to 
produce a molecular model of the HHA neuropeptide. Consistent with the 
secondary structure prediction, an anti-parallel ^ -pleated sheet topology was evident 
from the serine amino acid to the carboxyl terminus. Additionally, a /J-tum occurred 
near the amino carboxyl terminus. Results indicate that fluctuations occurring at both 
termini may serve to stabilize the structure ultimately allowing the amino terminus 
access to its receptor protein.
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Introduction
The Hydra head activator (HHA) neuropeptide was first isolated from the 
freshwater Hydra attenuta (Schaller and Bodenmiiller, 1981). In hydra, this 
neuropeptide is required for the growth and differentiation of the head region 
(Schaller et al., 1990). Subsequent studies have revealed HHA’s presence, with 
conserved amino acid sequence, in several species including mammals (Bodenmiiller 
and Schaller, 1981). More recently, the HHA has been chemically extracted from 
mammalian tissues including rat and human brain, intestine, and blood serum 
(Schaller et al., 1977; Schaller et al., 1988). Additionally, tumor cell lines and patients 
having brain tumors have been shown to possess an abundance of the HHA, as have 
developing rat and human embryos (Schaller et al., 1989; Schaller et al., 1988). 
These findings suggest a role for the HHA in growth and development in mammals.
The primary sequence of the HHA neuropeptide has been determined as 
pGlu1-Pro2-Pro3-Gly4-Gly5-Ser6-Lys7-Val8-Ile9-Leu10-Phe11, the amino terminus being 
pyroglutamic acid. This sequence displays little homology to other general sequences, 
although the bradykinins share a limited homology near the amino terminus 
(Xxx-Pro-Pro-Gly-Xxx-Ser). Interestingly, both peptides are able to stimulate ileum 
and uterus contraction (Schaller and Bodenmuller, 1981; Bodenmuller and Roberge, 
1985). Immunological and biochemical studies have shown that the neuropeptide’s
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action is receptor mediated and biologically inactivated by self-aggregation (Schaller 
et al., 1988; Bodenmiiller et al.,1986). Two receptors have been identified in the 
hydra which apparently mediate HHA’s biological activity, possibly via cyclic 
nucleotides (Neubauer et al., 1991; Kajiwara and Sato, 1986). Knowledge of the 
HHA-receptor interactions is limited. However, amino acid mutation studies as well 
as immunological assays demonstrate a crucial role by amino-terminal residues for 
receptor binding and biological activity. In fact, cleavage of the pGlu1 ring or its 
substitution by Tyr-Gln have resulted in biologically inactive peptides. Interestingly, 
alterations at the carboxyl terminal have also been effective in eliminating function 
(Birr et al., 1981).
Spectroscopic analysis and secondary structure prediction algorithms suggest a 
^-pleated conformation and a /3-tura near the center of the neuropeptide. 
Specifically, experimental data from CD and Raman spectroscopy estimate between 
62-67% /3-pleated sheet in the anti-configuration (Bodenmiiller et al.,1986). One and 
two-dimensional 2H-NMR experiments have been performed and are consistent with 
this secondary structure data (Saffrich et al., 1989). No structural heterogeneity in 
the solution structure was evident, implying only one dominant conformation within 
the NMR time-scale. Assigned NOEs indicate a trans-configuration for the peptide 
bonds between residues pGlu1, Pro2, and Pro3. Moreover, cleavage of the 
pyroglutamic ring did not induce any unexpected spectral modifications suggesting no
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global conformational changes. Together, this spectroscopic data has provided 
secondary structure information, although no detailed three-dimensional model has 
been reported. It is the purpose of the present study to predict a general topology 
for the hydra head activator neuropeptide.
A few strategies have been developed to enable the incorporation of 
experimental data, e.g. distance constraints derived from NOEs, to Cartesian 
coordinate space in order to obtain a three-dimensional topology (Crippen, 1977; 
Havel et ah, 1983). Recently, the PROTEAN methodology was introduced for 
protein solution structure determination. This method uses principles of Bayesian 
probability, namely the double-iterated Kalman filter procedure (DIKF), to 
sequentially refine estimates of the mean position and the variance of each atom. 
Thus a set of atomic positions consistent with the applied constraints, as well as an 
explicit quantification of the uncertainty in atomic position for each segment of the 
protein is provided (Altman and Jardetzky, 1989; Altman et al., 1989; Pachter et al., 
1990). The technique was shown to perform well for deriving a structure from NMR 
data of the cyclic peptide Cyclosporin A (Pachter et ah, 1992), the lac repressor 
headpiece (Altman et al., 1989), both the secondary structure (Arrowsmith et al., 
1990) and tertiary structure of the trp repressor (Arrowsmith et al., 1991), and of the 
Kunitz inhibitor domain of the amyloid precursor protein involved in Alzheimer’s 
disease (Batchelder, in prep.). In this study, we have used secondary structure data 
with the DIKF and CHARMm molecular dynamics modeling techniques to develop
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and analyze a detailed three-dimensional fold of the hydra head activator 
neuropeptide.
Materials and Methods
Theory of double iterated Kalman filter
The structural model is described by the state vector x which consists of a list 
of the mean positions (x, y, z cartesian coordinates) for each of the atoms in the 
protein. The elements of the general error covariance matrix C(x) for any two atoms
M, N are symmetric sub-matrices:
T &  xMxN xMyN G  xMzN 1
C(MN) = G  yMxN &  yMyN G  yMzN
L &  zMxN O  zMyN G  zMzN J
The variance-covariance matrices on the diagonal of the covariance matrix [C(MM)] 
describe the extent of three-dimensional uncertainty in the position of the atom M. 
The sequence of distance or dihedral angle measurements z are represented by the 
appropriate non-linear function of the state vector h(x) and an assumed additive 
variance v. Stereochemical constraints such as the co-planarity of peptide bonds, 
aromatic rings and chirality are introduced by using suitable dihedral angles, or 
alternatively, the appropriately derived distances. Distance constraints also include 
covalent bond lengths, distances implied by bond angles, NOE distance constraints 
and any non-standard connectivities, for example, hydrogen bonds. Given this 
information, a sequential linear estimator for the minimum variance estimate of the
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state can be obtained by utilizing the extended Kalman filter in the non-linear case 
(Gelb, 1984), originally introduced by Kalman (1960). This scheme is a conditional 
probability based (Bayesian) sequential estimation method, in which the experimental 
constraints z are compared with the corresponding values predicted from the 
estimated geometry of a given structure x and its variance-covariance C(x), as well 
as from the measurement model h(x) and the variance v :
x(+) = x(-) + K {z - h(x(-))} [1]
C (+) = C(-) - K H C(-)
K = C(-) EF {H C(-) HT + v}1
where (-) signifies a previous (-) structural representation, which is sequentially 
updated (+). The rigorous criterion for the choice of the Kalman estimator gain 
matrix K is to minimize a weighted scalar sum of the diagonal elements of the error 
covariance matrix C. Moreover, there is an intuitive logic behind the equation for 
the magnitude of the adjustment K, namely, it can be seen as the "ratio" between the 
uncertainty in the estimate and that of the measurement. Particularly, if the variance 
of the experimental measurement is small relative to the variance of the predicted 
measurement as calculated from the current structural model, then the structure is 
updated to bring it into agreement with the experimental data. On the other hand, 
if the variance of the experimental measurement is large relative to the variance of 
the predicted measurement, then the structural model is updated only slightly to 
reflect the greater confidence in the structure than in the uncertain data information. 
The term within the inverse describes {C(z) = C(h(x)) + v} for the particular 
condition of a non-linear measurement model, since in the case of non-linearity,
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C(h(x)) corresponds to the first-order Taylor approximation of h(x), where H is the 
derivative of the data model, and H its transpose.
The extended Kalman filter approach can be used to obtain higher-order 
non-linear filters, and we adopted an iterative procedure for this purpose (Denham 
and Pines, 1966). The iterated extended Kalman filter for an iteration k is obtained 
by re-writing Eq. [1] :
< + ) ,=  x(-) + K, {z - [« < + ) ,. ,)  + H(x(-) - x(+),.,)]> [2]
with similar expressions obtained for C (+)kand the appropriate K,.. This iterative 
procedure is carried out for each one of the constraints. However, since the filter is 
not optimal in the non-linear case, residual inaccuracies could still result. Thus, the 
final mean positions are used for another cycle (1) of updating. The covariance 
matrix is re-set to its initial large value in order to allow the atoms freedom to move 
in response to the constraints, and all measurements are re-introduced into the 
system for each of these doubly iterated cycles. These successive cycles are repeated 
until all constraints are satisfied to within a pre-set threshold of standard deviations.
The DI KF method is coded in the PROTEAN - Part II and was utilized in all
computations (Altman et al., 1990). The algorithm updates the structural model 
(equation [2]) for a maximum of three iterations (k) for each of the distance 
constraints, with a threshold of 0.1 standard deviations for termination of the iterative 
procedure, while the number of cycles (1) for reaching convergence varies according 
to the experiment performed. In addition, at the end of each cycle all of the distance 
constraints are sorted according to the corresponding error evaluated from the
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updated structure, so that the constraints with the worst errors are applied first in the 
next cycle.
Modeling of hydra head activator
The hydra head activator neuropeptide primary sequence was built using 
programs contained within PROTEAN - Part II. This sequence had a glutamine 
replacing the non-standard pyroglutamic residue. The input for the algorithm 
consisted of distance and angle constraints in the form of mean values along with 
associated variances. Specifically, distance variances were 0.1 A2 while angle 
variances remained at 25“2 The amino terminal Gin1, Pro2 and Pro3 0 2, an^ V>2 
angles were positioned at -55 “, -60“, and +145 “, respectively (Cantor and Schimmel, 
1980). Furthermore, ten omega angles (C„-C„) were set at 180“ of to retain a trans­
configuration across the peptide bond. Based on spectroscopic data, <p and ip 
backbone angles for Ser6, Lys7, Val8, He9 and 0  of Leu10 were placed at average values 
for anti-parallel ^ -pleated sheet (0 = -139 “, ip = +135 “) (Cantor and Schimmel, 1980). 
The aromatic ring of Phe11 was kept planar. Finally, 200 bond distances were 
assigned based on typical chemical bonding distances. In total, 228 angle and 
distance constraints were used as input to the structure determination computer 
algorithms coded in PROTEAN - Part II. This methodology allows a mean 
three-dimensional structure, consistent with experimental data, along with a variance 
and covariance of all atomic positions to be calculated.
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Further refinement of the three-dimensional structure was carried out by 
performing molecular mechanics and dynamics calculations. Prior to modeling, all 
atom and bond types were verified and the amino-terminal glutamine was converted 
to pyroglutamic acid. The modeling protocol involved an initial energy minimization 
using the CHARMm force field energy function (Brooks et al., 1983) and subsequent 
integration of the classical Newtonian equation of motion to determine the position 
of atoms at later time points. The CHARMm force field energy function contained 
all default terms, excluding hydrogen bonding. In addition, a dielectric constant of 
unity and a time step of 5 femtoseconds was used for the dynamics simulations. 
Routinely, 10,000 steps of Steepest Descent (SD) energy minimization followed by 
Conjugate Gradient (CG) minimization were employed prior to molecular dynamics 
simulations. The neuropeptide was initially heated to 300 °K over a 5 ps span. 
Equilibration and simulation periods were performed at 300 ’K for 5 ps and 50 ps, 
respectively. Over the 50 ps dynamics simulation, 1000 structures were written out 
for analysis. All computations were performed on a Cray X-MP and a Silicon 
Graphics Workstation.
Results
A three-dimensional fold for the hydra head activator neuropeptide was 
determined using experimental data derived from circular dichroism (CD) and 
nuclear magnetic resonance (NMR) in conjunction with theoretical techniques. After
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being subjected to 40 cycles of the extended double iterated Kalman filter algorithm 
(DIKF), the average variance of the initial structure converged to less than 0.1 
standard deviations (Figure 1). The mean position of the final structure from the 
DIKF calculation was subsequently used as a starting point for further refinement 
with molecular mechanics and dynamics.
The overall topology of the hydra head activator peptide is quite consistent 
with experimental data. Evident from the average dynamics structure (Figure 2 and 
Table I), the neuropeptide contains a /?-turn near the mid-region. This bend allows 
for spatial proximity and bonding interactions between the amino and carboxyl 
termini. As seen in Table I, residues near the carboxyl terminus have <j> and ip torsion 
angles within the range for anti-parallel ^ -pleated sheet conformation, 0 *» -139° and 
tp~ +135 ° (Cantor and Schimmel, 1980), while the amino terminus is less well defined.
The flexibility of the molecule is readily apparent by examining sequential 
coordinate frames of the dynamics simulation. However, a more quantitative 
measurement of flexibility can be seen in Figure 3, where the range of values for each 
0  and 0  torsion angle are plotted throughout the dynamics simulation. This plot 
emphasizes residues that demonstrate large fluctuations during the dynamics 
calculation. Transitions of 100° in the backbone angles are typical, though several 
residues show larger deviations. In particular, Pro3, Gly4, Gly5, Ser6 and Leu10 all 
display fluctuations near or over 200°. These residues represent regions of the 
neuropeptide having the most flexibility.
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It is interesting to examine particular torsions as a function of elapsed time 
during the dynamics simulation. In Figure 4, such plots are given for pGlu1, Pro3, and 
Leu10. For comparison, Figure 4b depicts the trace of 0 3 over time and shows typical 
oscillations around an average torsion of -74°. Furthermore, no unique or repeating 
transitions are present suggesting little impact upon the overall structure. In contrast, 
traces of and ipw (Figure 4a, 4c and 4d, respectively) exhibit larger fluctuations 
in torsion values. The variation in V’i and ipw is expected due to the inherent 
movement in unrestrained terminal residues. Their significance is underscored by 
mutational studies which indicate specific contacts between these residues are 
necessary for receptor binding and subsequent biological function (Birr et al., 1981; 
Schaller et al., 1989). Characteristic and repeating transitions are evident in ifo 
(Figure 4c). These distinct transitions can be characterized by two specific structural 
features as seen in Figure 5. When ip3 is above +140°, a highly stabilized structure 
containing a/J-tum is apparent (Figure 5a, 5b, and 5d). This model predicts extensive 
hydrogen bonding between residues comprising the /3-tum. Indeed, residues Pro3, 
Gly4, Gly5 and Ser6 show hydrogen bonding (Table II). Figure 5c and 5e, represent 
a structure where hydrogen bonding between the amino and carboxyl termini occurs 
periodically. This structure is characterized by interactions between pGlu1 and Val8, 
He9, Leu10 and Phe11 (Table II).
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Discussion
The determination of the three-dimensional structure of small peptides poses 
a special challenge to the researcher largely due to the inherent flexibility of peptide 
molecules (Dyson and Wright, 1991). In lieu of crystallographic data or sufficient 
NMR interatomic distances, this challenge can be prohibitive. Thus, theoretical 
approaches such as molecular dynamics and other algorithms have become important 
for elucidation of structural and energetic aspects of peptides (Hagler et. ah, 1985; 
Altman, 1990). Here, we have employed a methodology which incorporates readily 
available secondary structure data and a limited set of tertiary structural information
into a molecular model.
In general, this strategy is computationally efficient and accurate as long as 
each stage in the course offers the next one a rigorous upper bound (Altman et al., 
1989). This approach meets the major objections of Metzler et al. (1989) and Levy 
et al. (1989) to structure determination by distance geometry, since no structure is 
excluded from the system unless it does not satisfy the constraints. The estimates of 
mean and variance are updated using conservative constraint estimates one at a time, 
and there is no global optimization criteria which allows "error tradeoff' (a low 
average error at the expense of a few individually large errors). The resulting initial 
fold we calculated is therefore in good agreement with the experimental data.
The refined three-dimensional structure indicates that the neuropeptide 
contains a/2-tum near the mid-region, which enables spatial proximity and interaction
43
between the termini. Moreover, the flexibility revealed in the structure, especially for 
unrestrained terminal residues, is significant The importance of this point is 
emphasized by mutational studies which propose that specific contacts between these 
residues are important in receptor binding and biological function and inactivation 
by dimerization (Birr et ah, 1981; Bodenmuller et ah, 1986). In addition, the detailed 
molecular dynamics simulations enable us to discern interactions within the 
neuropeptide. Particularly, extensive hydrogen bonding is predicted between residues 
comprising the /?-tum, as well a between the termini.
In Figure 6, a qualatative model of the dimerized peptide is presented, based 
on the model proposed by Bodenmuller et al. (1986). This model, depicts the anti- 
parallel orientation of two HHA molecules apparently stabilized by hydrophobic 
contacts between residues near the mid-region /2-tum and hydrophobic carboxyl 
residues. Thus, one can imagine that by altering residues at either termini, crucial 
hydrogen bonding contacts can be disrupted important to biological function and
dimerization.
In summary, in this study we have presented an analysis of the three- 
dimensional structure of the HHA neuropeptide. It is shown that the DIKF 
representation captures the relative uncertainty of the atomic positions in the peptide 
in a useful way for structural comparison, as well as for analysis for the flexible 
regions or those ill defined by the data. Further, molecular dynamics simulations 
provide insight into the specific interactions present in the peptide, for an 
understanding of its biological activity.
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Figure 1. Average variance throughout DIKF calculation.
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Figure 2. Average structure o f the Hydra head activator neuropeptide. The structure 
was generated from the average <p and \p angles during the dynamics simulation.
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Figure 3. Plot o f the accessible torsions «p and tW sequentially along the backbone 
during 50 ps of dynamics simulation.
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Figure 4. Plot of the torsion angles^ and as a functions of time elapsed during the 
dynamics simulation for ^ i(a), f  3(b), ^ 3(c) and ^u(d).
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Figure 5. Characteristic structural features apparent during trace of ifo as a function 
of time.
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Figure 6. Proposed dimer structure o f HHA neuropeptide.
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Table I. Average 0  and ip angles for the hydra head activator during 50 ps of 
dynamics simulation.
Residue 0  (deg) IP (deg)
pGlu1 - 107
Pro2 - 61 + 138
Pro3 - 74 + 64
Gly4 - 15 + 59
Gly5 + 89 - 103
Ser6 - 92 - 24
Lys7 - 107 + 129
Val8 - 109 + 114
He9 - 95 + 123
Leu10 - 112 + 15
Phe11 - 113
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Table I I .  Summary of hydrogen bonding during the dynamics simulation.
CO(pGlu1)....NH(Lys7)* 
....NH(Leu10) 
______________...,NH(Pheu)
CO(Pro2)....NH(Gly4) 
CO(Pro3)....NH(Glys) 
CO(Gly4)....NH(Lys7) 
______________....NH(Sei*)
CO(Ser*)....NH(Lys7)
....NH(Val8)
CO(Lys7)....NH(Gly4) 
CO(Val8)....NH(pGlu1) 
_____________ ....NH(Leu10)
CO(Ile9)....NH(Phe11)
CO(Leu10)..-.COOH(Phen) 
* Signifies e-amino of lysine side group.
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